imidazo(1,2-a)pyridine has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baska, F; Boros, S; Dobos, J; Garamvölgyi, R; Illyés, E; Kékesi, L; Kéri, G; Őrfi, L; Sipos, A; Szabadkai, I; Szántai-Kis, C | 1 |
| Arama, DP; Bellet, V; Gallud, A; Garcia, M; Lichon, L; Lisowski, V; Maillard, LT; Martinez, J; Masurier, N | 1 |
2 other study(ies) available for imidazo(1,2-a)pyridine and Malignant Melanoma
| Article | Year |
|---|---|
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Imidazoles; Melanoma; Molecular Structure; Pyrazines; Pyridines; Structure-Activity Relationship | 2016 |
Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
Topics: Antineoplastic Agents; Azepines; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Melanoma; Pyridines; Structure-Activity Relationship | 2017 |